in patients with chronic brain syndrome and mental haldol discontinued in us and in the symptomatic control of Gilles de la Tourette's syndrome.ContraindicationsComatose states haldol discontinued in us CNS depression haldol discontinued in us to alcohol or other haldol discontinued in us drugs; severe depressive haldol discontinued in us previous spastic diseases; lesions of the basal.

by weakness, lethargy, fever, tremulousness and confusion, extrapyramidal symptoms, leukocytosis, elevated serum enzymes, BUN haldol discontinued in us FBS, haldol discontinued in us by irreversible haldol discontinued in us damage) haldol discontinued in us occurred in a few patients treated with lithium plus haloperidol. A causal relationship between these events haldol discontinued in us the concomitant administration haldol discontinued in us lithium haldol discontinued in us haloperidol has not been established; however, patients receiving such combined therapy should be monitored closely for early evidence of neurological toxicity and treatment haldol discontinued in us promptly if such signs appear.Elderly haldol discontinued in us debilitated patients receiving the drug should be carefully observed for lethargy and a decreased haldol discontinued in us of thirst due to central inhibition which might lead to dehydration and reduced pulmonary ventilation and could result in complications, such haldol discontinued in us haldol discontinued in us bronchopneumonia.Occupational Hazards:Although haloperidol is a relatively nonsedating neuroleptic, sedation may haldol discontinued in us in some haldol discontinued in us Therefore, physicians should be aware haldol discontinued in us this.

S, Eukystol, Haldol, Halosten, Keselan, Linton, Peluces, haldol discontinued in us Serenase, Sigaperidol) is a conventional, haldol discontinued in us typical, butyrophenone.